Limits...
Trends of genitourinary cancer among Saudis.

Abomelha MS - Arab J Urol (2011)

Bottom Line: An improvement in stage was only found in testicular and prostate cancer, at 79% and 50%, respectively.The incidence of GUC in Saudi Arabia is still low, but there was a significant increase in prostate and kidney cancer.More effort is needed to detect GUC at an earlier stage.

View Article: PubMed Central - PubMed

Affiliation: Advanced Medicine Center for Subspecialties, P.O. Box 1882, Riyadh 11441, Saudi Arabia.

ABSTRACT

Introduction: Saudi Arabia has a low incidence of cancer; the age-standardized rate of cancer is only 83/100,000, compared to the world rate of 181/100,000. Recent reports confirm a yearly increase in cancer in general, and of genitourinary cancer (GUC) in particular. The aim of the study was to assess the trends of GUC among Saudi nationals.

Methods: All available annual reports of the Saudi Cancer Registry (SCR) from 1994 to 2006 were analysed and compared with worldwide data.

Results: Over a period of 13 years, 7132 GUCs were identified among Saudis, comprising 8.9% of all cancers reported, compared to 12.7% worldwide. The incidence rate of GUC increased over the study period, with the greatest increase in prostate and kidney cancer, at 48% and 33%, respectively. Summary stage data (Surveillance, Epidemiology and End Results programme) showed late presentation of GUC at the time of diagnosis. An improvement in stage was only found in testicular and prostate cancer, at 79% and 50%, respectively. While prostate and bladder cancer ranked sixth and ninth in the male population, penile cancer continued to be a rare disease.

Conclusions: The incidence of GUC in Saudi Arabia is still low, but there was a significant increase in prostate and kidney cancer. More effort is needed to detect GUC at an earlier stage. A national cancer control programme is suggested.

No MeSH data available.


Related in: MedlinePlus

Cancer SEER summary stage (KFHS&RC). (A) prostate; (B) bladder, (C) kidney; (D) testicular.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4150577&req=5

f0015: Cancer SEER summary stage (KFHS&RC). (A) prostate; (B) bladder, (C) kidney; (D) testicular.

Mentions: Between 1994 and 2006, >80,000 cancer cases were reported by the SCR. GUC comprised 7132 cases, representing only 8.9% of all cancers reported. In bladder and kidney cancer the male to female ratio was 2.3:1 and the average age of patients for males was 64 years and for females 69 years. For prostate and testicular cancer the average age at presentation was 71 years and 32 years, respectively. The most common GUC was bladder cancer (3.1%), followed by prostate (2.8%), kidney (2.3%) and testicular cancer (0.6%). Penile cancer remains an extremely rare disease (0.03%). In the male population prostate and bladder cancer ranked sixth and ninth, respectively (Table 1). There was an annual increase of cancer over the study period and GUCs followed the same pattern (Fig. 1). The greatest increase in GUC was for prostate and kidney cancer (Fig. 2). The Surveillance, Epidemiology and End Results (SEER) summary stage data showed a late presentation of GUC at the time of diagnosis. There was an improvement in stage only for testicular and prostate cancer, at 79% and 50%, respectively (Fig. 3).


Trends of genitourinary cancer among Saudis.

Abomelha MS - Arab J Urol (2011)

Cancer SEER summary stage (KFHS&RC). (A) prostate; (B) bladder, (C) kidney; (D) testicular.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4150577&req=5

f0015: Cancer SEER summary stage (KFHS&RC). (A) prostate; (B) bladder, (C) kidney; (D) testicular.
Mentions: Between 1994 and 2006, >80,000 cancer cases were reported by the SCR. GUC comprised 7132 cases, representing only 8.9% of all cancers reported. In bladder and kidney cancer the male to female ratio was 2.3:1 and the average age of patients for males was 64 years and for females 69 years. For prostate and testicular cancer the average age at presentation was 71 years and 32 years, respectively. The most common GUC was bladder cancer (3.1%), followed by prostate (2.8%), kidney (2.3%) and testicular cancer (0.6%). Penile cancer remains an extremely rare disease (0.03%). In the male population prostate and bladder cancer ranked sixth and ninth, respectively (Table 1). There was an annual increase of cancer over the study period and GUCs followed the same pattern (Fig. 1). The greatest increase in GUC was for prostate and kidney cancer (Fig. 2). The Surveillance, Epidemiology and End Results (SEER) summary stage data showed a late presentation of GUC at the time of diagnosis. There was an improvement in stage only for testicular and prostate cancer, at 79% and 50%, respectively (Fig. 3).

Bottom Line: An improvement in stage was only found in testicular and prostate cancer, at 79% and 50%, respectively.The incidence of GUC in Saudi Arabia is still low, but there was a significant increase in prostate and kidney cancer.More effort is needed to detect GUC at an earlier stage.

View Article: PubMed Central - PubMed

Affiliation: Advanced Medicine Center for Subspecialties, P.O. Box 1882, Riyadh 11441, Saudi Arabia.

ABSTRACT

Introduction: Saudi Arabia has a low incidence of cancer; the age-standardized rate of cancer is only 83/100,000, compared to the world rate of 181/100,000. Recent reports confirm a yearly increase in cancer in general, and of genitourinary cancer (GUC) in particular. The aim of the study was to assess the trends of GUC among Saudi nationals.

Methods: All available annual reports of the Saudi Cancer Registry (SCR) from 1994 to 2006 were analysed and compared with worldwide data.

Results: Over a period of 13 years, 7132 GUCs were identified among Saudis, comprising 8.9% of all cancers reported, compared to 12.7% worldwide. The incidence rate of GUC increased over the study period, with the greatest increase in prostate and kidney cancer, at 48% and 33%, respectively. Summary stage data (Surveillance, Epidemiology and End Results programme) showed late presentation of GUC at the time of diagnosis. An improvement in stage was only found in testicular and prostate cancer, at 79% and 50%, respectively. While prostate and bladder cancer ranked sixth and ninth in the male population, penile cancer continued to be a rare disease.

Conclusions: The incidence of GUC in Saudi Arabia is still low, but there was a significant increase in prostate and kidney cancer. More effort is needed to detect GUC at an earlier stage. A national cancer control programme is suggested.

No MeSH data available.


Related in: MedlinePlus